Pet Tumor Screening Services Market Report – Research, Industry Analysis Reports and Market Demands

Global Pet Tumor Screening Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Pet Tumor Screening Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Pet Tumor Screening Services by Company Revenue
- 3.2.2 Top 3 Pet Tumor Screening Services Players Market Share in 2025
- 3.2.3 Top 6 Pet Tumor Screening Services Players Market Share in 2025
3.3 Pet Tumor Screening Services Market: Overall Company Footprint Analysis
- 3.3.1 Pet Tumor Screening Services Market: Region Footprint
- 3.3.2 Pet Tumor Screening Services Market: Company Product Type Footprint
- 3.3.3 Pet Tumor Screening Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Pet Tumor Screening Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Pet Tumor Screening Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Pet Tumor Screening Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Pet Tumor Screening Services Market Forecast by Application (2027-2032)

6 North America

6.1 North America Pet Tumor Screening Services Consumption Value by Type (2021-2032)
6.2 North America Pet Tumor Screening Services Market Size by Application (2021-2032)
6.3 North America Pet Tumor Screening Services Market Size by Country
- 6.3.1 North America Pet Tumor Screening Services Consumption Value by Country (2021-2032)
- 6.3.2 United States Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 6.3.3 Canada Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Pet Tumor Screening Services Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Pet Tumor Screening Services Consumption Value by Type (2021-2032)
7.2 Europe Pet Tumor Screening Services Consumption Value by Application (2021-2032)
7.3 Europe Pet Tumor Screening Services Market Size by Country
- 7.3.1 Europe Pet Tumor Screening Services Consumption Value by Country (2021-2032)
- 7.3.2 Germany Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 7.3.3 France Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 7.3.5 Russia Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 7.3.6 Italy Pet Tumor Screening Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Pet Tumor Screening Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Pet Tumor Screening Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Pet Tumor Screening Services Market Size by Region
- 8.3.1 Asia-Pacific Pet Tumor Screening Services Consumption Value by Region (2021-2032)
- 8.3.2 China Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 8.3.3 Japan Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 8.3.5 India Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 8.3.7 Australia Pet Tumor Screening Services Market Size and Forecast (2021-2032)

9 South America

9.1 South America Pet Tumor Screening Services Consumption Value by Type (2021-2032)
9.2 South America Pet Tumor Screening Services Consumption Value by Application (2021-2032)
9.3 South America Pet Tumor Screening Services Market Size by Country
- 9.3.1 South America Pet Tumor Screening Services Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Pet Tumor Screening Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Pet Tumor Screening Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Pet Tumor Screening Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Pet Tumor Screening Services Market Size by Country
- 10.3.1 Middle East & Africa Pet Tumor Screening Services Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Pet Tumor Screening Services Market Size and Forecast (2021-2032)
- 10.3.4 UAE Pet Tumor Screening Services Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Pet Tumor Screening Services Market Drivers
11.2 Pet Tumor Screening Services Market Restraints
11.3 Pet Tumor Screening Services Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Pet Tumor Screening Services Industry Chain
12.2 Pet Tumor Screening Services Upstream Analysis
12.3 Pet Tumor Screening Services Midstream Analysis
12.4 Pet Tumor Screening Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Pet Tumor Screening Services market size was valued at US$ 241 million in 2025 and is forecast to a readjusted size of US$ 459 million by 2032 with a CAGR of 9.8% during review period.
Pet tumor screening service is a comprehensive health screening service for pets such as dogs and cats, focusing on early detection and assessment of tumor risks. Through various methods such as hematology, imaging (such as ultrasound, X-ray, CT), and molecular biomarker detection, a systematic examination of various parts of the pet's body is conducted to achieve early tumor identification, risk assessment, and personalized health management plan development. This helps pet owners take timely intervention or treatment measures, improve the cure rate and quality of life.
As the pet population continues to grow and the status of pets within households rises, pet owners have demonstrated a significantly heightened focus on health management—particularly regarding the rapidly increasing demand for early screening of high-risk diseases such as tumors. Compared to traditional disease diagnosis and treatment, health check-up services offer distinct advantages in terms of prevention and scientific rigor. Consequently, within the landscape of pet healthcare consumption, these services exhibit a growth profile characterized by "high frequency, low risk, and high value." This trend is particularly evident in Tier 1 and Tier 2 cities, as well as in economically developed nations and regions, where the market penetration rate for such services is steadily on the rise.
From the supply side, pet oncology screening services are characterized by a focus on specialization and technological innovation. The continuous maturation of technologies—including blood tumor marker testing, diagnostic imaging, and AI-assisted diagnosis—has rendered health check-up results more precise and quantifiable. Concurrently, the integration of veterinary hospitals, specialized screening centers, and online telemedicine platforms has driven innovation in service delivery models—such as appointment-based check-ups, membership-based health management programs, and remote consultations—thereby further expanding market capacity and stimulating consumer willingness to spend. Overall, the market demonstrates robust growth potential and promising prospects for long-term development.
This report is a detailed and comprehensive analysis for global Pet Tumor Screening Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pet Tumor Screening Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Pet Tumor Screening Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Pet Tumor Screening Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Pet Tumor Screening Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pet Tumor Screening Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pet Tumor Screening Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., IDEXX Laboratories, Zoetis, VCA Animal Hospitals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pet Tumor Screening Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cut Biopsy
Needle Biopsy
Market segment by Technological Methodology
Imaging and Palpation Screening
Biochemical and Serological Screening
Molecular and Genomic Screening
Market segment by Risk Level Targeting
Low-Risk / Routine Screening
High-Risk / Breed-Specific Screening
Post-Treatment Monitoring
Market segment by Application
Pet Hospital
Clinic
Scientific Research Institutions
Market segment by players, this report covers
PetDx
CYTOGEN
BioChain
Small Door
ANGLE
BioChain Institute Inc.
CANCAN DIAGNOSTICS.
IDEXX Laboratories
Zoetis
VCA Animal Hospitals
AniCura
Anicom Holdings
Tokyo Pet Medical Center
Qiming Pet Hospital
RuiPai Pet
IDK Animal Diagnostics
Beijing Pet Medical Center
Baili Pet Health
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pet Tumor Screening Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pet Tumor Screening Services, with revenue, gross margin, and global market share of Pet Tumor Screening Services from 2021 to 2026.
Chapter 3, the Pet Tumor Screening Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pet Tumor Screening Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pet Tumor Screening Services.
Chapter 13, to describe Pet Tumor Screening Services research findings and conclusion.

Buy now